Accumulation of lipids and oxidatively damaged DNA in hepatocytes exposed to particles.

Toxicology and applied pharmacology (2013-10-15)
Lise K Vesterdal, Pernille H Danielsen, Janne K Folkmann, Line F Jespersen, Karin Aguilar-Pelaez, Martin Roursgaard, Steffen Loft, Peter Møller
RESUMEN

Exposure to particles has been suggested to generate hepatosteatosis by oxidative stress mechanisms. We investigated lipid accumulation in cultured human hepatocytes (HepG2) and rat liver after exposure to four different carbon-based particles. HepG2 cells were exposed to particles for 3h and subsequently incubated for another 18h to manifest lipid accumulation. In an animal model of metabolic syndrome we investigated the association between intake of carbon black (CB, 14nm) particles and hepatic lipid accumulation, inflammation and gene expression of Srebp-1, Fasn and Scd-1 involved in lipid synthesis. There was a concentration-dependent increase in intracellular lipid content after exposure to CB in HepG2 cells, which was only observed after co-exposure to oleic/palmitic acid. Similar results were observed in HepG2 cells after exposure to diesel exhaust particles, fullerenes C60 or pristine single-walled carbon nanotubes. All four types of particles also generated oxidatively damaged DNA, assessed as formamidopyrimidine DNA glycosylase (FPG) sensitive sites, in HepG2 cells after 3h exposure. The animal model of metabolic syndrome showed increased lipid load in the liver after one oral exposure to 6.4mg/kg of CB in lean Zucker rats. This was not associated with increased iNOS staining in the liver, indicating that the oral CB exposure was associated with hepatic steatosis rather than steatohepatitis. The lipid accumulation did not seem to be related to increased lipogenesis because there were unaltered gene expression levels in both the HepG2 cells and rat livers. Collectively, exposure to particles is associated with oxidative stress and steatosis in hepatocytes.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Oleic acid, ≥99% (GC)
Sigma-Aldrich
Palmitic acid, ≥99%
Sigma-Aldrich
Oleic acid, technical grade, 90%
Sigma-Aldrich
Oleic acid, suitable for cell culture, BioReagent
Supelco
Oleic acid, analytical standard
Sigma-Aldrich
Fullerene-C60, 99.5%
Sigma-Aldrich
Palmitic acid, BioXtra, ≥99%
Supelco
Palmitic acid, analytical standard
Sigma-Aldrich
Oleic acid, natural, FCC
Supelco
Palmitic acid, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Fullerene-C60, sublimed, 99.9%
Sigma-Aldrich
Palmitic acid, ≥95%, FCC, FG
Sigma-Aldrich
Fullerene-C60, 98%
Sigma-Aldrich
Palmitic acid, natural, 98%, FG
Sigma-Aldrich
Palmitic acid, ≥98% palmitic acid basis (GC)
Palmitic acid, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Fpg Protein from Escherichia coli, ≥90% (SDS-PAGE), recombinant, expressed in E. coli, buffered aqueous glycerol solution, >20,000 units/mg protein
Supelco
Palmitic acid, certified reference material, TraceCERT®
Supelco
Oleic acid, Selectophore, ≥99.0%